Fracture risk associated with the use of morphine and opiates - Wikidata - awgldk - TriplyDB

Fracture risk associated with the use of morphine and opiates

Fracture risk associated with the use of morphine and opiates

http://www.wikidata.org/entity/Q28219351

about

Opioid therapy pharmacogenomics for noncancer pain: efficacy, adverse events, and costs Potential impact of benzodiazepine use on the rate of hip fractures in five large European countries and the United States Opioid analgesics and the risk of fractures in older adults with arthritis Buprenorphine - an attractive opioid with underutilized potential in treatment of chronic pain Behavioral, medical imaging and histopathological features of a new rat model of bone cancer pain Implications of analgesics use in osteoporotic-related pain treatment: focus on opioids Endogenous opiates and behavior: 2006 High prevalence of central nervous system medications in community-dwelling older adults with dementia over a three-year period.Evaluating the affect and reversibility of opioid-induced androgen deficiency in an orthopaedic animal fracture model.Women, Aging, and HIV: Clinical Issues and Management Strategies.Relationship of opioid use and dosage levels to fractures in older chronic pain patients Pain characteristics associated with the onset of disability in older adults: the maintenance of balance, independent living, intellect, and zest in the Elderly Boston Study The effects of opioids and opioid analogs on animal and human endocrine systems Opioid induced hypogonadism.Prospective study of bone mineral density changes in aging men with or at risk for HIV infection.Risk of injury associated with opioid use in older adults.Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women.Treating postmenopausal osteoporosis in women at increased risk of fracture - critical appraisal of bazedoxifene: a review Guidance on the management of pain in older people.Medication-induced osteoporosis: screening and treatment strategies Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patients Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine.Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address them.Prevalence of low bone mineral density in a low-income inner-city population The unsolved case of "bone-impairing analgesics": the endocrine effects of opioids on bone metabolism.Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population.Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations.Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis Opioids contribute to fracture risk: a meta-analysis of 8 cohort studies.New advances in musculoskeletal pain.The effectiveness of a new generation of computerized drug alerts in reducing the risk of injury from drug side effects: a cluster randomized trial.Medication use and functional status decline in older adults: a narrative review.A Review of Potential Adverse Effects of Long-Term Opioid Therapy: A Practitioner's Guide Tramadol and the risk of fracture in an elderly female population: a cost utility assessment with comparison to transdermal buprenorphine.Spinal and paraspinal lesions: the role of stereotactic body radiotherapy.Hypogonadism and low bone mineral density in patients on long-term intrathecal opioid delivery therapy.Switching to low-dose oral prolonged-release oxycodone/naloxone from WHO-Step I drugs in elderly patients with chronic pain at high risk of early opioid discontinuation.Orally administered H-Dmt-Tic-Lys-NH-CH2-Ph (MZ-2), a potent mu/delta-opioid receptor antagonist, regulates obese-related factors in mice.Current status of adult spinal deformity.Opioid receptor agonists may favorably affect bone mechanical properties in rats with estrogen deficiency-induced osteoporosis.

P2860

Q21284753-5B664DA1-2FC6-434E-9DF8-67C3E6106EBC Q24598759-3FD7F326-887B-49F5-8334-1046AEA91231 Q24607425-10A44207-0BC4-4E21-8050-F0A8597D787C Q26775658-BC5E4254-AA70-4D98-8E02-16795C661107 Q27317157-D98E4C5D-7FA0-4C4E-A7BC-C1F193200602 Q28071550-1A423669-93CD-41A5-AAE9-282AB8412DD8 Q28752585-357CE396-FF62-4AA3-87FC-92CDE77EA6C0 Q33155526-FB41456F-4BBB-4A94-BE6D-20F3B2C893E8 Q33592228-87EE39FD-3A03-41C6-9D39-0EA856B2A4E0 Q33730038-D3D03258-B605-42A3-83D2-4BF8A4699C1C Q33742530-74F09FED-2D73-4F0F-B017-F28DE2DA3845 Q33756863-81DE707C-5713-472F-83B9-3F9979C1D9F2 Q33779667-D3FF4A99-C882-43C0-B75C-D27B79B1E58F Q34023723-1BF094D5-B9C2-4B15-B6B3-9CC4D5C353E8 Q34116648-23A00461-2605-4644-A74E-89945D458410 Q34139657-C8AD29AE-182D-4BA4-924E-953585B50167 Q34192064-322CE94F-E325-403F-B920-F977FF63BD2B Q34271979-3BA1EC39-2F5A-4330-9ABB-A23C3D69AC01 Q34328425-ED466D9D-C7BD-4A58-AF98-02D0716E098D Q34389358-209D4B8E-FBC7-42AF-8224-7A0DF47323B9 Q34787421-690A5FBC-4AB4-47C4-AF8A-95BA79CCFAC8 Q34787766-F79E9B9F-1A71-4A63-956B-43ECABF9A4A7 Q35214415-4F7BBADC-5912-409B-B0D0-D57276CB0C60 Q35230039-8078FDB3-C32A-44DC-A60F-2533B17BF8BF Q35284151-9B32F086-C729-4391-A5BB-568B4E86AC0B Q35548497-B40396D5-BD9A-4B28-A3FF-391245C793D8 Q35548503-F73CDBDF-B9B2-41DB-9731-0D67EB09B43D Q35581451-DC37E279-B8C2-4615-943C-CD4DD5F6A3A6 Q35647987-D28BC4EB-43FF-4324-B6C2-043868441344 Q35701568-51B7891A-5A44-4ACE-990A-103FE88CFD47 Q36061252-9027F551-F4B1-48E7-A83D-E59D95A69154 Q36099587-C824CEB0-C28B-408F-B612-C0A727B8C29B Q36302851-65A08D8B-8A57-40D5-976D-8E6AB1A8F70A Q36590805-0A6C80AA-C261-4816-8F92-5E9F54AF4876 Q36887077-730AB77C-8A2E-409E-BFD6-C1C34CB74C5D Q36893653-E1A924C5-89AD-45A4-963C-75B834CF7467 Q36921570-D537F4BB-0BB2-4652-8182-A294BD2D41C6 Q37361349-11256BDC-628D-4134-9FF5-DBAF01CEE4FD Q37376297-2FD96FE2-D120-441E-8FE4-2D3D2643878C Q37584104-B8ED7021-E34E-43A9-93A0-2A5F7143545A

P2860

Fracture risk associated with the use of morphine and opiates

http://www.wikidata.org/entity/Q28219351

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Fracture risk associated with the use of morphine and opiates

@ast

Fracture risk associated with the use of morphine and opiates

@en

Fracture risk associated with the use of morphine and opiates

@nl

type

label

Fracture risk associated with the use of morphine and opiates

@ast

Fracture risk associated with the use of morphine and opiates

@en

Fracture risk associated with the use of morphine and opiates

@nl

prefLabel

Fracture risk associated with the use of morphine and opiates

@ast

Fracture risk associated with the use of morphine and opiates

@en

Fracture risk associated with the use of morphine and opiates

@nl

P1433

Q28219351-5A4A3662-9934-4643-8DA7-7DB0CDC78A0C

P1476

Q28219351-00448A30-1364-4EAB-9779-87A7B4D125DF

P2093

Q28219351-195AB6E2-A1D3-4970-BC63-516F18BA7564

Q28219351-FF0FEC36-E8E6-422F-8DE0-A8E0058D6A25

P2860

Q28219351-0FD1D040-312D-4A1B-8314-8D59BE5F927D

Q28219351-1EED72C1-9F74-442D-868F-11AC7293022E

Q28219351-21832412-17E5-479C-825C-3BA1E1C32A11

Q28219351-27415473-0487-4F5D-A48A-43B080B37003

Q28219351-5D8ACF64-9D7C-44CB-A16D-DD3681781B49

Q28219351-6BB8F6E0-6C4D-44D7-8C52-2D8915B98F44

Q28219351-8E390AB8-D388-4BA0-A70E-96932BFA3BBA

Q28219351-B7C8D241-2115-4FA1-BA62-E367551F336E

Q28219351-C8120E62-2013-4E2C-BBD4-D0BD8D97D65A

Q28219351-CD8171F8-A195-4194-B648-5F344FBB938B

P304

Q28219351-0522C87F-211D-4AD7-AA8E-4FD0AA0498CF

P31

Q28219351-60D2B1AE-1A32-402E-8EC1-98B0C21FD742

P3181

Q28219351-1633412A-1B10-4672-86BA-4373D2886BDA

P356

Q28219351-8D2242E5-87A0-43AD-9E44-1EC4C51C1822

P407

Q28219351-96FD4B5B-8594-4EF3-BD5E-1B6F156E031F

P433

Q28219351-49647B54-4E98-4684-B445-C46D07D44F33

P478

Q28219351-DFBABF18-AB51-4096-AEB4-9AF0005BF578

P50

Q28219351-6CD84BF6-7B4D-44B3-B4BB-7F88F7628399

P577

Q28219351-45817D0B-B2E8-477D-BD07-4CEEE462DB85

P5875

Q28219351-7AF883F8-ED13-4E5D-BEA6-23B1E76415F8

P698

Q28219351-E86935A6-6A9B-4D20-93EF-94BBAC30EB96

P921

Q28219351-B6DB3212-08CB-411E-9815-AD74E532AE97

P3181

P356

J.1365-2796.2006.01667.X

P1433

Journal of Internal Medicine

P1476

Fracture risk associated with the use of morphine and opiates

@en

P2093

Mosekilde L

http://www.w3.org/2001/XMLSchema#string

Vestergaard P

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiology. When an entire country is a cohort

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

How to measure comorbidity. a critical review of available methods.

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism.

Comparison of valdecoxib and an oxycodone-acetaminophen combination for acute musculoskeletal pain in the emergency department: a randomized controlled trial.

Central nervous system-active medications and risk for falls in older women.

The direct medical costs of osteoporosis for American women aged 45 and older, 1986.

Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation.

Central nervous system active medications and risk for fractures in older women.

P304

76-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1640589

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/J.1365-2796.2006.01667.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

260

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6994330

http://www.w3.org/2001/XMLSchema#string

P698

16789982

http://www.w3.org/2001/XMLSchema#string

P921